BIO-MODELING SYSTEMS France

Bio-Modeling Systems is the world’s first Mechanisms-Based medicine company that changed the discovery paradigm to create novel medical meanings from unreliable heterogeneous sources of data to generate validated & directly exploitable first in class heuristic non-mathematical mechanistic CADI™* models

Created in 2004, profitable since 2006, thanks to our recurrent clients, we confirmed with our partners CADI™ Discovery capability to generate outstanding value through:

·         Dual business model: Contractual or Collaborative R&D programs.

·         External valorization of our collaborative R&D programs through out-licensing or spin-off.

·         Outstanding internal pipeline of programs ready for collaborations, and

·         Already a world's first in neurodegenerative diseases, 1 therapeutic spin-off, 1 exclusive out-license, 4 issued patents, 10 publications (for all details, visit BMSystems website).

We propose to Research, Discovery, Development people, considering that 90-95% failure rate is unacceptable but not a fatality, robust alternative solutions for their critical issues and decisions to make. 

You have a question; we may have the ability to generate the answer through one of our 6 BMSystems’ solutions to critical & high impact issues.

1.       GO-NO GO decision before product acquisition or for portfolio risk analysis.

2.       GO-NO GO decision before next development phase.

3.       R&D program Rescue for a program facing critical issues during its lifetime.

4.       External R&D “B plan” program when the “A plan” cannot be rescued.

5.       Exploratory Discovery program to generate novel causal mechanisms concepts.

6.       Novel Hypotheses for therapeutic and/or diagnostic solutions generation.

 

We warmly invite you to download our  7 pages management summary,  our Short corporate Presentation or our Full Presentation with all non-confidential details of our 10 POCs.

 

"Correct understanding of life mechanisms makes novel integrated diagnostics, therapies & preventive solutions discovery smarter, faster & cheaper for healthcare, diagnostic, health technologies, nutrition, and cosmetics!" 

MANUEL GEA
MANUEL GEA
Co-founder & CEO 

BIOMODEX France

Mr Thomas Marchand
CEO 

BIOMODEX France

Jean Hennequin
CFO 

C. Texdev France

CTEXDEV develops Augmentative and Alternative Communication (AAC) applications called CommunicoTool, to help non-verbal individuals to communicate.

Industry sectors  E_health


Therapeutics Area  Psychiatry/Psychology

Our innovative solution

 CommunicoTool is an Augmentative and Alternative Communication (AAC) application that provide language communication features including: pictures and pictograms, prerecorded voice, speech synthesis, speech/pain assessment, time management. The application is fully configurable by the end users. Our service is available in French and English in a bilingual version.

Problem  solved

CommunicoTool is an application for tablets suitable for patients with ASD, Stroke, LAS, Cerebral pulsy, with language and communication disorders. Just for ASD, The CDC (Centers for Disease Control and Prevention) estimates about 1 percent of the world population (7 billion) has autism spectrum disorder, and more than 25% of them are non-verbal. 

Market segments

ASD / Stroke / LAS / Cerebral pulsy

Key value proposition

Accessibility / price / Innovation / Configurable

Frederic Guibet
CEO - Founder 

Care Labs France

Care Labs Edition, management and marketing of prepaid voucher : healthcare voucher Industry sectors E health Therapeutics Area Dental and Oral Health
Dermatology
Nutrition and Weight Loss
Orthopedics/Orthopedic Surgery
Psychiatry/Psychology
Your innovative solution

CHEQUE SANTE

Which problem are you solving ?

The costs of healthcare become more and more disabling for the modern-day families. Because of these costs, they tend to avoid taking medical appointments. Our objective is to allow every individual to be the master of his own health capital.

Target market segments

Firms, Works Council, Mutual insurance companies, Insurances?

Key value proposition

Prepaid voucher, Online appointment setting, Intelligent health record, Directory of the healthcare professionals

Vincent DAFFOURD
PrĂ©sident 

CLEANIS France

CLEANIS Cleanis invents and manufactures a range of medical grade bags with absorbent pad for the management of body fluids and which are clinically proven to be very effective in the containment of Healthcare-Associated Infections (H.A.I.) such as VRE or the deadly and highly prevalent Clostridium difficile. Cleanis invents and manufactures innovative hygiene medical products for the safe management of body fluids such as sanitary absorbent liners; clinically proven to be very effective in the containment of Hospital Acquired Infections (H.A.I.) Industry sectors Medtech Therapeutics Area Infectious Diseases - Vaccines
Your innovative solution

Carebag is a range of green friendly medical grade bags and liners equipped with a super absorbent pad, designed to replace or cover collection containers such as bedpan ; thus providing a safe solution for the collection, transport and disposal of body fluids whether infectious or not. Made with innovative polymers.

Which problem are you solving ?

The excretas and body fluids management. Carebag has multiple benefits: improvement of hygiene and infection control ; decrease of infection rate ; reduction of Healthcare-Associated Infections (H.A.I.) such as the deadly and highly prevalent C diff. ; substantial cost savings generated by the Reduction of nursing and PPE savings.

Target market segments

Where collection containers such as bedpans or commode pails are used: Hospital (10 to 15% of hospitalization with the support of Infection Preventionnist, especially ICU, Emergency dpt, PACU, post op, cancer treatment center 

Key value proposition

Innovation: Inventor of the product / Leader / Continuous innovation / IP

LAURENT HELEWA
President 

CleveXel Pharma France

CLEVEXEL Pharma invests its teams' know-how to catalyze innovative drug development projects and ensure their attractiveness on the market.

We are an integrated, one-stop-shop solution for the co-development of promising new therapeutic compounds. We partner with inventors to boost the development of their product from proof-of-concept in an animal model to proof-of-concept in human. The project is then outlicensed to a pharmaceutical company for Phase III and Market Access.

Christian BLOY
PRESIDENT 
Mr Adrien Decque
Coordinateur scientifique 

CNCCEF - ICT France

Present in 146 countries, CCEs form an active network of over 4,000 members at the service of French companies around the world.


Selected for their competence and their international experience, the 'Conseillers du Commerce extérieur de la France' (CCE - French Foreign Trade Advisor) are appointed for three years through a prime ministerial decree, on the recommendations of the Minister for Foreign Trade. For more than 115 years, on a voluntary basis, they have been placing their experience at the service of France's economic presence around the world.

Mr Gilbert Reveillon
President ICT & CDO 

CreaPharm group France

CREAPHARM GROUP Providing customized international clinical supplies solutions to meet your needs & Improving your patients

CreaPharm group is a customer-focused team of 164 people applying their expertise and innovative solutions to offer a first-class service to their 250 active customers.

We are a mid-size subcontractor that is big enough to offer high range of services of the highest quality while at the same time being small enough to offer dedicated care and to adapt its processes according to the specificities of each client request.

Our 4 facilities are fully compliant with Good Manufacturing Practices and Good Distribution Practices and are inspected by the French medicines agency ANSM for human medicinal products and the ANSES for veterinary products.

Our team has years of experience in managing all types of projects with agility, flexibility and responsiveness.

Clinical Supplies:

·         GMP manufacturing,

·         Packaging and labelling,

·         International distribution,

·         Comparator and ancillary goods sourcing,

·         IMP importation and QP release services,

·         Biological sampling kit production

 

Pharmaceutical Contract Manufacturing:

·         Packaging design and development, Packaging of market drugs,

·         Special packing and repacking activities,

·         Late stage customization

 

Cosmetic Contract Manufacturing:

·         Formulation of cosmetic products,

·         A wide range of formulas available,

·         Packaging design and development, Manufacturing & packaging of cosmetic products

Mrs Carla DA COSTA
Business Development Director 

CYTOSIAL Biomedic France

CYTOSIAL Biomedic is a pre-clinical medical device startup dedicated to applying its patented chitosan-based breakthrough technology and expertise to the development of medical devices for regenerative medicine and tissue engineering.

FREDERIC BERTAINA
FREDERIC BERTAINA
Ceo